home page

Board of Directors

Andrew Sandham, (Chairman)
Lawrence Bloch, MD, JD
David Brand
Aaron Davidson
Kenneth Galbraith
Jonathan R. Goodman
Deepa Pakianathan, PhD
Samuel P. Wertheimer, PhD

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board



Jonathan R. Goodman, CEO, Paladin Labs

Prior to founding Paladin, Jonathan was the Vice President of Business Development at Pharmascience Inc. where he led Pharmascience’s successful efforts to in-license new products and develop key corporate alliances with such companies as Eli Lilly, Schering, Novartis, Berlex, Alcon and Fournier. In addition, Jonathan was a consultant with Bain & Company, a management consulting concern and also worked in brand management for Procter & Gamble. Jonathan holds a B.A. with Great Distinction from McGill University and the London School of Economics with 1st Class Honours as well as an LL.B. and MBA from McGill. Jonathan is a member of the Bars of New York and Massachusetts, is an Accredited Pharmaceutical Manufacturing Representative, is a sessional lecturer in entrepreneurship at McGill University and is a part-time faculty member of Concordia University.

 

Home | NeurAxon | Market | Pipeline | Research | News | Contact